A new research study has found that banning menthol cigarettes does not lead more smokers to purchase menthols from illicit sources, contradicting claims made by the tobacco industry that the proposed ban of menthol cigarettes ...
Jan 12, 2023
0
7
Europe and North America have seen shortages of the key antibiotic amoxicillin and other medications as surging illnesses particularly among children have increased demand for the drugs.
Dec 20, 2022
0
15
Drug companies must make fundamental changes to their core business to address R&D gaps and access to existing medicines for women's sexual and reproductive health in lower-income countries, global health equity advocates ...
Dec 12, 2022
0
14
The U.S. Food and Drug Administration (FDA) should extend the ban on menthol-flavored cigarettes and cigars to include potential substitutes like menthol pipe tobacco and cigarette tubes, say researchers at Rutgers Center ...
Dec 5, 2022
0
80
For years, brand drug companies have been villainized for "evergreening" or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year patent—a practice critics say unfairly prevents competition ...
Nov 3, 2022
0
4
The cost of family health insurance plans increased just 1% this year even as inflation reached a four-decade high, with higher prices for gas, groceries, rent and other living expenses.
Oct 31, 2022
0
3
The New Zealand parliament is currently considering a new smokefree law to implement key components of the Smokefree Aotearoa 2025 Action Plan.
Oct 19, 2022
0
20
In an article published in the journal Science, a group of international researchers, including Gorka Orive, Doctor of Pharmacy and researcher in the UPV/EHU's NanoBioCel group, and Unax Lertxundi of the Bioaraba Institute ...
Oct 11, 2022
0
8
A new study concludes that the 2020 European ban on menthol cigarettes made it more likely that menthol smokers would quit smoking, supporting previous Canadian research on the positive public health impact of banning menthol ...
Sep 27, 2022
0
10
In the first known study of its type, an international team of researchers evaluated whether high research and development (R&D) costs explain high drug prices in the United States.
Sep 26, 2022
1
82
